Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin’s Lymphoma von Johnson, Peter, Federico, Massimo, Kirkwood, Amy, Fosså, Alexander, Berkahn, Leanne, Carella, Angelo, d’Amore, Francesco, Enblad, Gunilla, Franceschetto, Antonella, Fulham, Michael, Luminari, Stefano, O’Doherty, Michael, Patrick, Pip, Roberts, Thomas, Sidra, Gamal, Stevens, Lindsey, Smith, Paul, Trotman, Judith, Viney, Zaid, Radford, John, Barrington, Sally

Volltext

PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study von Barrington, Sally F., Kirkwood, Amy A., Franceschetto, Antonella, Fulham, Michael J., Roberts, Thomas H., Almquist, Helén, Brun, Eva, Hjorthaug, Karin, Viney, Zaid N., Pike, Lucy C., Federico, Massimo, Luminari, Stefano, Radford, John, Trotman, Judith, Fosså, Alexander, Berkahn, Leanne, Molin, Daniel, D'Amore, Francesco, Sinclair, Donald A., Smith, Paul, O'Doherty, Michael J., Stevens, Lindsey, Johnson, Peter W.

Volltext

Role of fluorodeoxyglucose positron emission tomography (FDG PET)‐computed tomography (CT) in the staging of bladder cancer von Goodfellow, Henry, Viney, Zaid, Hughes, Paul, Rankin, Sheila, Rottenberg, Giles, Hughes, Simon, Evison, Felicity, Dasgupta, Prokar, O'Brien, Timothy, Khan, Muhammad Shamim

Volltext

Comparison of the diagnostic performance and impact on management of 18F-FDG PET/CT and whole-body MRI in multiple myeloma von Westerland, Olwen, Amlani, Ashik, Kelly-Morland, Christian, Fraczek, Michal, Bailey, Katherine, Gleeson, Mary, El-Najjar, Inas, Streetly, Matthew, Bassett, Paul, Cook, Gary J. R., Goh, Vicky

Volltext

Phase 2 Study of Sorafenib in Malignant Mesothelioma Previously Treated with Platinum-Containing Chemotherapy von Papa, Sophie, Popat, Sanjay, Shah, Riyaz, Prevost, A. Toby, Lal, Rohit, McLennan, Blair, Cane, Paul, Lang-Lazdunski, Loic, Viney, Zaid, Dunn, Joel T., Barrington, Sally, Landau, David, Spicer, James

Volltext

PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor (AZD6738) as a single agent... von Dillon, Magnus, Ellis, Sally, Grove, Lorna, McLellan, Lyndall, Clack, Glen, Smith, Dr Simon, Laude, Jennifer, Viney, Zaid, Adeleke, Sola, Lazaridis, George, Spicer, James F., Forster, Martin David, Harrington, Kevin J.

Volltext

PET-CT for staging & early response: results from 'Response Adapted Therapy in Advanced Hodgkin Lymphoma' (RATHL) (CRUK/07/033) von Barrington, Sally F, Kirkwood, Amy A, Franceschetto, Antonella, Fulham, Michael J, Roberts, Thomas H, Almquist, Helén, Brun, Eva, Hjorthaug, Karin, Viney, Zaid N, Pike, Lucy C, Federico, Massimo, Luminari, Stefano, Radford, John, Trotman, Judith, Fosså, Alexander, Berkahn, Leanne, Molin, Daniel, D'Amore, Francesco, Sinclair, Donald A, Smith, Paul, O'Doherty, Michael J, Stevens, Lindsey, Johnson, Peter W

Volltext